Anixa Biosciences (ANIX) Amortizatization of Intangibles (2013 - 2014)
Anixa Biosciences' (ANIX) quarterly Amortizatization of Intangibles came in at $59057.0 in Q4 2014, down 39.76% YoY from $98031.0 in Q4 2013, and down 54.22% on a QoQ basis from $129000.0 in Q3 2014.
Anixa Biosciences (ANIX) Amortizatization of Intangibles (2013 - 2014) Analysis & Trends
Anixa Biosciences (ANIX) has 2 years of Amortizatization of Intangibles data on file, last reported at $59057.0 in Q4 2014.
- Quarterly Amortizatization of Intangibles fell 39.76% year-over-year to $59057.0 in Q4 2014, while the trailing twelve-month figure through Oct 2014 was $520373.0 (up 26.35% YoY) and the FY2014 annual result came in at $634267.0, down 36.01% from the prior year.
- Amortizatization of Intangibles eased to $59057.0 in Q4 2014, from $129000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $229964.0 in Q3 2013 to a low of $5234.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2014 | 59,057.00 |
| Oct 31, 2014 | 59,057.00 |
| Jul 31, 2014 | 129,000.00 |
| Jul 31, 2014 | 129,000.00 |
| Apr 30, 2014 | 115,000.00 |
| Apr 30, 2014 | 115,000.00 |
| Jan 31, 2014 | 217,316.00 |
| Jan 31, 2014 | 217,316.00 |
| Oct 31, 2013 | 98,031.00 |
| Oct 31, 2013 | 98,031.00 |
| Jul 31, 2013 | 229,964.00 |
| Jul 31, 2013 | 229,964.00 |
| Apr 30, 2013 | 78,617.00 |
| Apr 30, 2013 | 78,617.00 |
| Jan 31, 2013 | 5,234.00 |
| Jan 31, 2013 | 5,234.00 |